ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
Rubfila International has scheduled a board meeting on November 12, 2026 to approve unaudited quarterly results for the quarter ended September 30, 2026. The trading window stays closed until 48 hours after the meeting.
Rubfila International filed its quarterly shareholding pattern for the quarter ended September 30, 2026. This is a periodic statement of holdings with no transaction or corporate event.
Rubfila International Ltd submitted the Regulation 74(5) certificate from its RTA, confirming compliance with SEBI's depository regulations for the quarter ended September 2026.
Rubfila International Ltd received a request from Mrs. Bharati B. Dattani to reclassify her 1.28% stake from the Promoter to the Public category under SEBI regulations.
Rubfila International Ltd conducted its 33rd Annual General Meeting on September 29, 2026. Shareholders discussed the adoption of financial statements, dividend declaration, and divestment of Premier Tissues India Ltd.
Rubfila International fixed 22-Sep-2026 as the record date for its FY25-26 final dividend. The declared rate is Rs.2 per equity share of Rs.5 face value.
Rubfila board approved reclassifying Mrs. Bharati Dattani from Promoter to Public category under Reg 31A. Her ~1.28% equity holding exits the promoter group.
Rubfila International Limited will conduct its 33rd Annual General Meeting on September 29, 2026, to discuss financial statements, dividends, and the divestment of its subsidiary.
Rubfila International Ltd filed its 33rd AGM notice. The agenda includes approval for divesting its entire shareholding in subsidiary Premier Tissues India Ltd for ₹61 Crore.
Rubfila International will divest its entire stake in subsidiary Premier Tissues (India) to Finquest Personal Care for an aggregate consideration of ₹61.00 Crore.
Rubfila International has scheduled a board meeting for August 20, 2026, to convene the 33rd Annual General Meeting and consider a subsidiary's valuation report.
Rubfila International Ltd reported revenue from operations of ₹133.5 Cr (-7.9% YoY) and net profit of ₹5.8 Cr (-13.4% YoY) for Q1 FY27.
Rubfila International Ltd has scheduled a board meeting for August 11, 2026, to approve the standalone and consolidated unaudited financial results for the June quarter.
Mr. Bharat J Dattani resigned as Non-Executive Director of Rubfila International Limited effective July 16, 2026. The company has recorded the departure as per regulatory requirements.
Rubfila International recommended a final dividend of ₹2 per equity share for 2026. Payment remains subject to shareholder approval at the upcoming General Meeting.
Rubfila International Ltd reported revenue from operations of ₹160.6 Cr (+8.9% YoY) and net profit of ₹6.4 Cr (-22.9% YoY) for Q4 FY26.
Rubfila International Ltd reported audited annual financial results for the period ended March 31, 2026. The Board also recommended a final dividend of Rs.2 per share.
Rubfila International scheduled a board meeting on May 26, 2026. Directors will approve annual financial results and consider recommending a dividend for shareholders.
Rubfila International Limited submitted its SDD compliance certificate for the quarter ended March 31, 2026. The company confirmed that it maintains a non-tamperable digital database for UPSI as required by SEBI (PIT) Regulations. No non-compliances were reported during the period.
Rubfila International Ltd submitted a compliance certificate for the quarter ended March 31, 2026, as per SEBI regulations. The certificate confirms that security certificates received for dematerialisation were processed, cancelled, and substituted in the register of members within 15 days.
Rubfila International Ltd reported net profit of ₹5.5 Cr (-31.2% YoY) for Q3 FY26.